# Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

> **NCT03394612** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **CUTISS AG** · enrollment: 20 (estimated)

## Conditions studied

- Skin Wound

## Interventions

- **BIOLOGICAL:** EHSG-KF
- **BIOLOGICAL:** STSG

## Key facts

- **NCT ID:** NCT03394612
- **Lead sponsor:** CUTISS AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-14
- **Primary completion:** 2023-12-01
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03394612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03394612, "Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03394612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*